United Therapeutics | Fremdkapital



Loan Capital Veränderung Datum
Amarin USD 0 0 2024-09
Ardelyx USD 150.85M 50.15M 2024-12
Baxter International USD 10.37B 63M 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Insmed USD 1.13B 147.77M 2024-12
Intra Cellular Therapies USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
J&J USD 30.65B 638M 2024-12
Moderna USD 39M 586M 2024-12
Pfizer USD 57.4B 597M 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Teva Pharmaceutical Industries USD 16B 398M 2024-12
United Therapeutics USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



United Therapeutics Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.